相关实验视频

Updated: Jun 21, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

目标治疗的夸张:"KRAS (p.G12C) " - - 简化一个复杂的生物学问题的简化

Massimiliano Chetta¹, Anna Basile², Marina Tarsitano¹

¹U.O.C. Medical and Laboratory Genetics, A.O.R.N., Cardarelli, 80131 Naples, Italy.

|July 13, 2024

概括

克拉斯基因突变驱动许多癌症. 虽然索托拉西布向KRAS p.G12C,但它的有效性是复杂的. 这项研究揭示了KRAS异型和突变的独特结构动态,影响治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
计算化学计算化学

背景情况:

基因突变涉及非小细胞肺癌 (NSCLC),结直肠癌 (CRC) 和胰腺导管腺癌 (PDAC).
由于缺乏典型的药物结合部位,向KRAS一直是具有挑战性的,尽管已经出现了针对p.G12C突变的Sotorasib等特定抑制剂.
最近的临床试验数据 (CodeBreaK 200) 显示,Sotorasib在NSCLC中没有显著的整体存活益处比Docetaxel,这凸显了KRAS向治疗的复杂性.

研究的目的:

为了比较KRAS4A和KRAS4B异构体的三维结构.
研究由常见的KRAS突变 (p.G12C,p.G12D,p.G12V) 引起的索托拉西布结合口袋中的结构变化.
阐明这些结构变异对KRAS聚合倾向和寡合状态的影响.

主要方法:

KRAS4A 和 KRAS4B 的三维结构比较.
在索托拉西布结合域内,通过KRAS突变 (p.G12C,p.G12D,p.G12V) 诱导的结构变化的计算分析.
对野生类型和突变KRAS异型的聚合倾向和寡合组合的评估.

主要成果:

对于KRAS4A和KRAS4B异构体,已经确定了明显的三维结构.
计算分析显示,由于KRAS突变,索托拉西布的口袋域可能发生结构变化.
野生类型和突变的KRAS单体表现出不同的聚合倾向,导致不同的寡合体配置.

结论:

克拉斯异型及其突变的结构动态对治疗向具有重大复杂性.
对KRAS结构行为的更深入的理解对于设计更有效的抗癌药物至关重要.
计算方法为KRAS介导的瘤发生提供了宝贵的见解,可以帮助开发新的治疗策略.

关键词:

在KRAS的同位体 (KRAS4AA.KRAS4B) 的情况.在 p.G12C 突变中.索托拉西布 (AMG 510) 的使用

更多相关视频

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Protein Networks

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...